Please could you complete and SHARE this GCAQE
International COVID-19 airline employee survey.
The GCAQE is currently working with leading health experts to produce 'fumes guidance' material.
This is expected to be available in late 2020.
LONG TERM HEALTH EFFECTS
Neurotoxic symptoms: numbness (fingers, lips, limbs), parathesias;
Neuropsychological or psychotoxic symptoms: memory impairment, forgetfulness, lack of coordination, severe headaches, dizziness balance, sleep disorders;
Gastro-intestinal symptoms: salivation, nausea, vomiting, diarrhoea;
Respiratory symptoms: breathing difficulties (shortness of breath), tightness in chest, respiratory failure, susceptibility to upper respiratory tract infections;
Cardiovascular symptoms: chest pain, increased heart rate and palpitations;
Skin symptoms: skin itching and rashes, skin blisters (on uncovered body parts), hair loss;
Irritation of eyes, nose and upper airways;
Sensitivity: signs of immunosuppression, chemical sensitivity leading to acquired or multiple chemical sensitivity
General: weakness and fatigue (leading to chronic fatigue), exhaustion, hot flashes, joint pain, muscle weakness and pain.
SHORT TERM HEALTH EFFECTS
Neurotoxic symptoms: blurred or tunnel vision, nystagmus, disorientation, shaking and tremors, loss of balance and vertigo, seizures, loss of consciousness, parathesias;
Neuropsychological or psychotoxic symtoms: memory impairment, headache, light-headedness, dizziness, confusion and feeling intoxicated;
Gastro-intestinal symptoms: nausea, vomiting;
Respiratory symptoms: cough, breathing difficulties (shortness of breath), tightness in chest, respiratory failure requiring
Cardiovascular symptoms: increased heart rate and palpitations;
Irritation of eyes, nose and upper airways.
Other symptoms are being reported by crew and passengers
There are an extensive number of papers, reports and finding related to the health effects consequential to exposure to contaminated air on aircraft.
A few are listed below for guidance: